Form 4: Kiora Pharmaceuticals CFO Melissa Tosca Acquires Additional Shares
SEC Form 4 Filing
Melissa Tosca, CFO of Kiora Pharmaceuticals, recently purchased 2,000 shares of the company's common stock at an average price of $3.21.
Summary
- On August 14, 2024, Melissa Tosca, the CFO of Kiora Pharmaceuticals, acquired 2,000 shares of common stock.
- The purchase was made at an average price of $3.21 per share, with individual transactions ranging from $3.16 to $3.26.
- Following the transaction, Ms. Tosca directly owns 13,599 shares of Kiora Pharmaceuticals.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO's purchase indicates confidence, but it's a relatively small transaction.
Positives
- The CFO's purchase of shares could be interpreted as a positive signal about her confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The stock purchase could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of the stock purchase transaction. |
| 08/15/2024 | Date of signature on the Form 4 filing. |
Keywords
Kiora Pharmaceuticals, Melissa Tosca, CFO, stock purchase, Form 4, KPRX, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.